5-Alpha-Reductase Inhibitor for Benign Prostatic Hyperplasia: A Review of Volume-Selected Therapy and Safe Prostate Cancer Detection
World Journal of Nephrology and Urology · 2026-07 · 15 (3) · 65-70
DOI: 10.14740/wjnu1055 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Nephrology and Urology, 2026-07. Verfasst von Enoch Chi Ngai Lim und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lim, E. C. N., & Lim, C. E. D. (2026). 5-Alpha-Reductase Inhibitor for Benign Prostatic Hyperplasia: A Review of Volume-Selected Therapy and Safe Prostate Cancer Detection. World Journal of Nephrology and Urology, 15(3), 65-70. https://doi.org/10.14740/wjnu1055
Vancouver
Lim ECN, Lim CED. 5-Alpha-Reductase Inhibitor for Benign Prostatic Hyperplasia: A Review of Volume-Selected Therapy and Safe Prostate Cancer Detection. World Journal of Nephrology and Urology. 2026;15(3):65-70. doi:10.14740/wjnu1055
BibTeX
@article{Lim2026,
author = {Lim, Enoch Chi Ngai and Lim, Chi Eung Danforn},
title = {5-Alpha-Reductase Inhibitor for Benign Prostatic Hyperplasia: A Review of Volume-Selected Therapy and Safe Prostate Cancer Detection},
journal = {World Journal of Nephrology and Urology},
year = {2026},
volume = {15},
number = {3},
pages = {65--70},
doi = {10.14740/wjnu1055}
}
EUVIMED